Ophthalmic Viscosurgical Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Ophthalmic Viscosurgical Devices Market is Segmented by Type (Cohesive, Dispersive, and Viscoadaptive), Source (Biological, Animal, and Semi-synthetic), Application (Glaucoma Surgery, Cataract Surgery, Corneal Grafting, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Ophthalmic Viscosurgical Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Ophthalmic Viscosurgical Devices Market Size

Ophthalmic Viscosurgical Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 6.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Ophthalmic Viscosurgical Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Ophthalmic Viscosurgical Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Ophthalmic Viscosurgical Devices Market Analysis

The Ophthalmic Viscosurgical Devices Market is expected to register a CAGR of 6.5% during the forecast period.

Initially, with the increasing COVID-19 cases around the world, governments around the globe implemented lockdown measures to stop the spread of the SARS-CoV-2 virus, which not only led to a drop in footfall in clinics and hospitals for eye care but also led to the cancellation or postponement of many procedures which had its impact on the patients as well as the studied market. For instance, according to a research study published by Parul C Gupta et al. in 2021 in the Indian Journal of Ophthalmology, the studied clinic was expected to perform 7,500 cataract procedures. Still, due to the pandemic, they could serve only 2,500 procedures. This data suggested a significant decrease in cataract procedures during the COVID-19 pandemic. As per the research study published by Gabriel Ayubet. al., in November 2021, on the comparison of the pre-pandemic and pandemic periods data for glaucoma patients in a tertiary center, it was observed the total number of outpatient clinical visits, visual field exams, surgical procedures, and medications released decreased by 92.52%, 93.84%, 72.74%, and 19.63%, respectively. This data shows a negative impact of COVID-19 on diagnosing and treating ocular disorders; thus, the market suffered negatively. Moreover, the market has been making a strong comeback since the limitations were lifted and normalized the supply chain. Increased outpatient visits and the removal of all restrictions on ophthalmic procedures have been driving the market recovery over the projected period.

This is attributed to the rapidly increasing geriatric population, increasing prevalence of diabetes, and an increasing number of cataract and glaucoma surgeries performed. The rising geriatric population worldwide is more prone to ocular disorders. For instance, the data published in October 2021 by the World Health Organization (WHO) reported that the pace of population aging is much faster than in the past, and by 2030, 1 in 6 people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2030. Thus, an increase in the geriatric population is expected to boost market growth over the forecast period.

Diabetes can damage the eyes, resulting in vision problems or even blindness. People with diabetes may experience various eye issues known as diabetic eye disease. These ailments include glaucoma, cataracts, diabetic macular, and diabetic retinopathy, and thus growing prevalence of diabetes is expected to cause eye diseases, thereby boosting the market growth. For instance, according to the IDF Diabetes Atlas Tenth Edition 2021, diabetes has affected around 537 million persons (20-79 years) in 2021 across the world. Diabetes is expected to affect 643 million people by 2030 and 783 million by 2045. Thus, the increasing prevalence of diabetes, the most common cause of ophthalmic disease, is expected to boost the market over the forecast period.

However, the availability of alternative procedures may hamper the market growth.

Ophthalmic Viscosurgical Devices Industry Overview

The ophthalmic viscosurgical devices market is moderately competitive and consists of several major players. Some of the companies currently dominating the market include Johnson & Johnson, Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Rayner Intraocular Lenses Limited, Alcon AG, Beaver-Visitec International Inc., Bohus Biotech AB, Truviz Ophthalmic, and Amring Pharmaceutical Inc.

Ophthalmic Viscosurgical Devices Market Leaders

  1. Carl Zeiss Meditec AG

  2. Bausch & Lomb Incorporated

  3. Rayner Intraocular Lenses Limited

  4. Alcon AG

  5. Johnson & Johnson

  6. *Disclaimer: Major Players sorted in no particular order
Picture1.png
Need More Details on Market Players and Competiters?
Download PDF

Ophthalmic Viscosurgical Devices Market News

  • September 2022: Bausch + Lomb Corporation announced that seven scientific podium and poster presentations involved its products and pipeline, as well as data from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study, which includes ClearVisc dispersive ophthalmic viscosurgical device.
  • February 2022: Rayner, a British manufacturer, and distributor of intraocular lenses (IOLs) and ophthalmic treatments, has opened a regional office in Sydney to manage its product distribution directly. In addition, Rayner intends to expand its product line to include ophthalmic viscosurgical devices and dry eye solutions (AEON), which are currently available in regions outside of Australia.

Ophthalmic Viscosurgical Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapidly Increasing Geriatric Population
    • 4.2.2 Increasing Prevalence of Diabetes
    • 4.2.3 Increasing Number of Cataract and Glaucoma Surgeries Performed
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Treatment Procedures
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Cohesive
    • 5.1.2 Dispersive
    • 5.1.3 Viscoadaptive
  • 5.2 By Source
    • 5.2.1 Biological
    • 5.2.2 Animal
    • 5.2.3 Semi-synthetic
  • 5.3 By Application
    • 5.3.1 Glaucoma Surgery
    • 5.3.2 Cataract Surgery
    • 5.3.3 Corneal Grafting
    • 5.3.4 Other Applications
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Johnson & Johnson
    • 6.1.2 Carl Zeiss Meditec AG
    • 6.1.3 Bausch & Lomb Incorporated
    • 6.1.4 Rayner Intraocular Lenses Limited
    • 6.1.5 Alcon AG
    • 6.1.6 Beaver-Visitec International Inc.
    • 6.1.7 Bohus Biotech AB
    • 6.1.8 Truviz Ophthalmic
    • 6.1.9 Amring Pharmaceutical Inc.
    • 6.1.10 Advin Health Care
    • 6.1.11 Ophtechnics Unlimited
    • 6.1.12 EC21 Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Ophthalmic Viscosurgical Devices Industry Segmentation

As per the scope of the report, ophthalmic viscosurgical devices are used in several ocular surgeries to guard the delicate ocular structure and to maintain space in the anterior chamber of an eye, leading to faster and safer surgery. These devices are composed of sodium hyaluronate, chondroitin sulfate, and hydroxypropyl methylcellulose. The market is segmented by type (cohesive, dispersive, and viscoadaptive), source (biological, animal, and semi-synthetic), application (glaucoma surgery, cataract surgery, corneal grafting, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Type Cohesive
Dispersive
Viscoadaptive
By Source Biological
Animal
Semi-synthetic
By Application Glaucoma Surgery
Cataract Surgery
Corneal Grafting
Other Applications
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Ophthalmic Viscosurgical Devices Market Research FAQs

What is the current Ophthalmic Viscosurgical Devices Market size?

The Ophthalmic Viscosurgical Devices Market is projected to register a CAGR of 6.5% during the forecast period (2025-2030)

Who are the key players in Ophthalmic Viscosurgical Devices Market?

Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Rayner Intraocular Lenses Limited, Alcon AG and Johnson & Johnson are the major companies operating in the Ophthalmic Viscosurgical Devices Market.

Which is the fastest growing region in Ophthalmic Viscosurgical Devices Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Ophthalmic Viscosurgical Devices Market?

In 2025, the North America accounts for the largest market share in Ophthalmic Viscosurgical Devices Market.

What years does this Ophthalmic Viscosurgical Devices Market cover?

The report covers the Ophthalmic Viscosurgical Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Ophthalmic Viscosurgical Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Ophthalmic Viscosurgical Devices Industry Report

Statistics for the 2025 Ophthalmic Viscosurgical Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Ophthalmic Viscosurgical Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.